Affymetrix Chief Medical Officer to speak at AAAS on Personalized Medicine

Affymetrix, Inc., (Nasdaq: AFFX) today announced that its Chief Medical Officer, Dr. Rick Hockett, will address the topic of ‘Personalized Medicine: Planning for the Future’ at a meeting of the American Association for the Advancement of Science (AAAS) and the Food and Drug Law Institute (FDLI) on June 1 in Washington, DC.

Source: Affymetrix